Assessment and management of iatrogenic withdrawal syndrome and delirium in pediatric intensive care units across Europe: An ESPNIC survey

Author:

Sperotto Francesca1ORCID,Ramelet Anne‐Sylvie2ORCID,Daverio Marco3ORCID,Mondardini Maria Cristina4ORCID,von Borell Florian5,Brenner Sebastian5ORCID,Tibboel Dick6ORCID,Ista Erwin7ORCID,Pokorna Paula78910,Amigoni Angela3ORCID,

Affiliation:

1. Cardiovascular Critical Care Unit Department of Cardiology Boston Children's Hospital Harvard Medical School Boston Massachusetts USA

2. Institute of Higher Education and Research in Healthcare Faculty of Biology and Medicine University of Lausanne Lausanne Switzerland

3. Pediatric Intensive Care Unit Department of Women's and Children's Health University Hospital of Padua Padua Italy

4. Pediatric Anesthesia and Intensive Care Unit Department of Woman's and Child's Health IRCCS University Hospital of Bologna Policlinico S.Orsola Bologna Italy

5. Department of Pediatrics Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden Dresden Germany

6. Intensive Care and Department of Paediatric Surgery Erasmus MC‐Sophia Children’s Hospital University Medical Center Rotterdam Rotterdam The Netherlands

7. Department of Neonatal & Pediatric Intensive Care Division Pediatric Intensive Care, Erasmus MC‐Sophia Children’s Hospital University Medical Center Rotterdam Rotterdam Netherlands

8. Institute of Pharmacology First Faculty of Medicine Charles University and General University Hospital Prague Czech Republic

9. Department of Paediatrics and Inherited Metabolic Disorders First Faculty of Medicine Charles University and General University Hospital Prague Czech Republic

10. Department of Physiology and Pharmacology Karolinska Institutet and Karolinska University Hospital Stockholm Sweden

Abstract

AbstractIntroductionAnalgesia and sedation are essential for the care of children in the pediatric intensive care unit (PICU); however, when prolonged, they may be associated with iatrogenic withdrawal syndrome (IWS) and delirium. We sought to evaluate current practices on IWS and delirium assessment and management (including non‐pharmacologic strategies as early mobilization) and to investigate associations between the presence of an analgosedation protocol and IWS and delirium monitoring, analgosedation weaning, and early mobilization.MethodsWe conducted a multicenter cross‐sectional survey‐based study collecting data from one experienced physician or nurse per PICU in Europe from January to April 2021. We then investigated differences among PICUs that did or did not follow an analgosedation protocol.ResultsAmong 357 PICUs, 215 (60%) responded across 27 countries. IWS was systematically monitored with a validated scale in 62% of PICUs, mostly using the Withdrawal Assessment Tool‐1 (53%). The main first‐line treatment for IWS was a rescue bolus with interruption of weaning (41%). Delirium was systematically monitored in 58% of PICUs, mostly with the Cornell Assessment of Pediatric Delirium scale (48%) and the Sophia Observation Scale for Pediatric Delirium (34%). The main reported first‐line treatment for delirium was dexmedetomidine (45%) or antipsychotic drugs (40%). Seventy‐one percent of PICUs reported to follow an analgosedation protocol. Multivariate analyses adjusted for PICU characteristics showed that PICUs using a protocol were significantly more likely to systematically monitor IWS (odds ratio [OR] 1.92, 95% confidence interval [CI] 1.01–3.67) and delirium (OR 2.00, 95% CI 1.07–3.72), use a protocol for analgosedation weaning (OR 6.38, 95% CI 3.20–12.71) and promote mobilization (OR 3.38, 95% CI 1.63–7.03).ConclusionsMonitoring and management of IWS and delirium are highly variable among European PICUs. The use of an analgosedation protocol was associated with an increased likelihood of monitoring IWS and delirium, performing a structured analgosedation weaning and promoting mobilization. Education on this topic and interprofessional collaborations are highly needed to help reduce the burden of analgosedation‐associated adverse outcomes.

Publisher

Wiley

Subject

Pharmacology (medical)

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3